Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RG

Richard Gregory — 25 Patents

GEGenzyme: 16 patents #24 of 891Top 3%
CACanji: 8 patents #2 of 50Top 4%
University of California: 1 patents #8,022 of 18,278Top 45%
Carlsbad, CA: #227 of 2,500 inventorsTop 10%
California: #22,079 of 386,348 inventorsTop 6%
Overall (All Time): #158,593 of 4,157,543Top 4%
25 Patents All Time
Richard Gregory has been granted 25 US patents while listed as an inventor at Genzyme. The first was granted in 1997 and the most recent in January 2008. Richard Gregory ranks #158,593 of 4,157,543 US inventors in our database (top 3.8%). Patent records list Richard Gregory in Carlsbad, CA, US.

Patents per Year

Patents granted per year, 1997 to 2008Bar chart with a peak of 6 patents in 1999.peak 61997: 1 patents19971998: 1 patents19981999: 6 patents19992000: 4 patents20002001: 2 patents20012002: 4 patents20022005: 1 patents20052006: 5 patents20062008: 1 patents2008

Issued Patents All Time

Showing 1–25 of 25 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7318919 Adenovirus vectors for gene therapy Donna Armentano, Larry A. Couture, Alan E. Smith 2008-01-15 $140,588,000
7118911 DNA molecules stabilized for propagation in bacterial cells that encode cystic fibrosis transmembrane conductance regulator Seng H. Cheng, Alan E. Smith, Sucharita Paul, Kathleen M. Hehir, John Marshall 2006-10-10 $48,007,000
7105156 Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells Wen-Hwa Lee, H. Michael Shepard, Ken Wills, Daniel C. Maneval, Eva Lee +2 more 2006-09-12 $71,279,000
7053062 Compositions and methods for inducing gene expression Karen Vincent 2006-05-30 $98,002,000
7041284 Recombinant adenoviral vector and method of use Ken Wills, Daniel C. Maneval 2006-05-09 $32,359,000
6989268 Recombinant adenoviral vector and methods of use Ken Wills, Daniel C. Maneval 2006-01-24 $141,642,000
6902731 Methods of treating hyperproliferative disorders using retinoblastoma fusion proteins Douglas Antelman, Kenneth Nelson Wills 2005-06-07 $55,356,000
6485720 Transgene expression systems Johanne Kaplan, Donna Armentano 2002-11-26
6432927 Compositions and methods for inducing gene expression Karen Vincent 2002-08-13
6379927 Retinoblastoma fusion proteins Douglas Antelman, Kenneth Nelson Wills 2002-04-30
6358507 Transgene expression systems Johanne Kaplan, Donna Armentano 2002-03-19
6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy Ronald K. Scheule, Rebecca G. Bagley, Simon J. Eastman, Seng H. Cheng, John Marshall +8 more 2001-12-18
6210939 Recombinant adenoviral vector and methods of use Ken Wills, Daniel C. Maneval 2001-04-03
6100086 Transgene expression systems Johanne Kaplan, Donna Armentano 2000-08-08
6093567 Gene therapy for cystic fibrosis Donna Armentano, Larry A. Couture, Alan E. Smith 2000-07-25
6074850 Retinoblastoma fusion polypeptides Douglas Antelman, Kenneth Nelson Wills 2000-06-13
6020191 Adenoviral vectors capable of facilitating increased persistence of transgene expression Abraham Scaria, Samuel Wadsworth 2000-02-01
5981275 Transgene expression system for increased persistence Donna Armentano, John Marshall, Nelson S. Yew, Seng H. Cheng 1999-11-09
5981714 Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor Seng H. Cheng, John Marshall, Patrick W. Rafter 1999-11-09
5932210 Recombinant adenoviral vector and methods of use Ken Wills, Daniel C. Maneval 1999-08-03
5882877 Adenoviral vectors for gene therapy containing deletions in the adenoviral genome Donna Armentano, Larry A. Couture, Alan E. Smith 1999-03-16
5877011 Chimeric adenoviral vectors Donna Armentano, Alan E. Smith 1999-03-02
5876974 Method for producing DNA encoding cystic fibrosis transmembrane conductance regulator (CFTR) protein in E. coli 1999-03-02
D399112 Windshield wiper reconditioner David Rubin Gregory 1998-10-06
5670488 Adenovirus vector for gene therapy Donna Armentano, Larry A. Couture, Alan E. Smith 1997-09-23